Sugi T, Makino T, Maruyama T, Nozawa S, Iizuka R
Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo, Japan.
Am J Reprod Immunol. 1993 Mar;29(2):95-9. doi: 10.1111/j.1600-0897.1993.tb00572.x.
The mechanism of the beneficial effect of immunotherapy for human reproductive wastage remains to be elucidated. Because some women with unexplained recurrent spontaneous abortion are immunized with their partner's lymphocytes, it is important to determine whether such immunization results in elevation or enhancement of immunity to spermatozoa, because antigenic cross-reactivity between lymphocytes and spermatozoa has been reported.
The present study was initiated to evaluate the changes in antisperm antibody titer and lymphocyte subsets after immunotherapy as compared to before immunotherapy. Antisperm antibody detection was performed by SpermCheck Assay, which is based on a modification of the immunobead test. Maternal lymphocyte subsets were analyzed in two-color flow-cytometric experiments.
The percentage of antibody-positive sperm decreased significantly (P = 0.0008) after immunotherapy. The percentage of B(CD19+) cells (P = 0.0003), cytotoxic T(CD8+ and CD11b-) cells (P = 0.02) and the Th/Ts ratio (P = 0.005) decreased significantly, while suppressor T(CD8+ and CD11b+) cells increased significantly (P = 0.0002) after the immunotherapy. This suggests that cell-mediated immunosuppression was induced by immunotherapy.
The data of the present study suggest that antisperm antibodies have potential for use as a marker for a deficiency in maternal genital tract immunosuppressor mechanisms and that immunotherapy could be an effective treatment for women with antisperm antibodies who have unexplained recurrent abortions.
免疫疗法对人类生殖损耗产生有益作用的机制仍有待阐明。由于一些原因不明的复发性自然流产女性会接受其伴侣淋巴细胞的免疫治疗,鉴于已报道淋巴细胞与精子之间存在抗原交叉反应,因此确定这种免疫治疗是否会导致对精子的免疫升高或增强至关重要。
本研究旨在评估免疫治疗前后抗精子抗体滴度和淋巴细胞亚群的变化。抗精子抗体检测采用基于免疫珠试验改良的SpermCheck检测法。在双色流式细胞术实验中分析母体淋巴细胞亚群。
免疫治疗后抗体阳性精子的百分比显著降低(P = 0.0008)。免疫治疗后,B(CD19 +)细胞百分比(P = 0.0003)、细胞毒性T(CD8 +和CD11b -)细胞百分比(P = 0.02)以及Th/Ts比值(P = 0.005)显著降低,而抑制性T(CD8 +和CD11b +)细胞显著增加(P = 0.0002)。这表明免疫治疗诱导了细胞介导的免疫抑制。
本研究数据表明,抗精子抗体有可能作为母体生殖道免疫抑制机制缺陷的标志物,并且免疫治疗可能是针对有不明原因复发性流产且存在抗精子抗体的女性的一种有效治疗方法。